相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Dennis S. W. Lee et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Toll-like receptor signalling in B cells during systemic lupus erythematosus
Simon Fillatreau et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Interleukin-17 in rheumatoid arthritis: Trials and tribulations
Leonie S. Taams
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population - the Nord-Trondelag Health Study
Ingrid Saether Houge et al.
SCIENTIFIC REPORTS (2020)
mTORC1 Signaling Controls TLR2-Mediated T-Cell Activation by Inducing TIRAP Expression
Takayuki Imanishi et al.
CELL REPORTS (2020)
The pathogenicity of Th17 cells in autoimmune diseases
Keiko Yasuda et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Systemic TLR2 tolerance enhances central nervous system remyelination
Nicholas J. Wasko et al.
JOURNAL OF NEUROINFLAMMATION (2019)
TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders
Aleida S. O. Dias et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Recent clinical trends in Toll-like receptor targeting therapeutics
Muhammad Ayaz Anwar et al.
MEDICINAL RESEARCH REVIEWS (2019)
Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice
Mohamed Alibashe-Ahmed et al.
SCIENTIFIC REPORTS (2019)
Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis
Thais B. Ferreira et al.
IMMUNOLOGY (2018)
The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
Md Jakir Hossain et al.
FRONTIERS IN IMMUNOLOGY (2018)
Enhanced TLR2 responses in multiple sclerosis
M. Fujiwara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Toll-like receptors in lupus nephritis
Satish Kumar Devarapu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy
Jian Ye et al.
JOURNAL OF IMMUNOLOGY (2017)
Fatty acid synthase regulates the pathogenicity of Th17 cells
Kathryne E. Young et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Inhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Encephalomyelitis Induced in Mice
Shira Dishon et al.
FRONTIERS IN IMMUNOLOGY (2017)
T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45RbHi T cells
Janice C. Jun et al.
PLOS ONE (2017)
TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype
Lilian Quero et al.
ARTHRITIS RESEARCH & THERAPY (2017)
TLRs, future potential therapeutic targets for RA
Hatem A. Elshabrawy et al.
AUTOIMMUNITY REVIEWS (2017)
TLR Tolerance as a Treatment for Central Nervous System Autoimmunity
Emily J. Anstadt et al.
JOURNAL OF IMMUNOLOGY (2016)
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
Eva Havrdova et al.
JOURNAL OF NEUROLOGY (2016)
Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
Patricia Lacerte et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus
Kongyang Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
TLR2 Stimulation Regulates the Balance between Regulatory T Cell and Th17 Function: A Novel Mechanism of Reduced Regulatory T Cell Function in Multiple Sclerosis
Mukanthu H. Nyirenda et al.
JOURNAL OF IMMUNOLOGY (2015)
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain
Pragnesh Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease
Lisa M. Mullen et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Toll-like Receptor 2 Is Required for Autoantibody Production and Development of Renal Disease in Pristane-Induced Lupus
Vilma Urbonaviciute et al.
ARTHRITIS AND RHEUMATISM (2013)
TLR2 deletion promotes arthritis through reduction of IL-10
Qi-Quan Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice
Simon J. Freeley et al.
PLOS ONE (2013)
SNAPIN: an endogenous toll-like receptor ligand in rheumatoid arthritis
Bo Shi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Toll-like Receptors in Systemic Lupus Erythematosus: Potential Targets for Therapeutic Intervention
Christopher G. Horton et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2012)
Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation
Joseph M. Reynolds et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
Sridevi Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
Sudhanshu Agrawal et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Inhibition of Autoimmune Diabetes by TLR2 Tolerance
Do-Hoon Kim et al.
JOURNAL OF IMMUNOLOGY (2011)
TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function
Mukanthu H. Nyirenda et al.
JOURNAL OF IMMUNOLOGY (2011)
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
F. Jadidi-Niaragh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
Nathaniel M. Green et al.
SEMINARS IN IMMUNOLOGY (2011)
The Structural Biology of Toll-like Receptors
Istvan Botos et al.
STRUCTURE (2011)
Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
Sinead Nic An Ultaigh et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Burden of Mortality Associated With Autoimmune Diseases Among Females in the United Kingdom
Sara L. Thomas et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
IL-17 family member cytokines: Regulation and function in innate immunity
Joseph M. Reynolds et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
Joseph M. Reynolds et al.
IMMUNITY (2010)
IL-10 Mediates Resistance to Adoptive Transfer Experimental Autoimmune Encephalomyelitis in MyD88(-/-) Mice
Shmuel J. Cohen et al.
JOURNAL OF IMMUNOLOGY (2010)
Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization
Jeremy P. McAleer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2
J. A. Sloane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Yeonseok Chung et al.
IMMUNITY (2009)
Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus
Aurelia Lartigue et al.
JOURNAL OF IMMUNOLOGY (2009)
Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms
Jorge Correale et al.
JOURNAL OF IMMUNOLOGY (2009)
The role of Toll-like receptors in rheumatoid arthritis
Qi-Quan Huang et al.
Current Rheumatology Reports (2009)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Asa Andersson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Danger-free autoimmune disease in Aire-deficient mice
Daniel H. D. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis
QiQuan Huang et al.
ARTHRITIS AND RHEUMATISM (2007)
Gene-specific control of inflammation by TLR-induced chromatin modifications
Simmie L. Foster et al.
NATURE (2007)
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice
Atsushi Sadanaga et al.
ARTHRITIS AND RHEUMATISM (2007)
Expression and function of Toll-like receptors in T lymphocytes
Dieter Kabelitz
CURRENT OPINION IN IMMUNOLOGY (2007)
Toll-like receptors in systemic autoimmune disease
Ann Marshak-Rothstein
NATURE REVIEWS IMMUNOLOGY (2006)
TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation
Anne Cottalorda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Imbalance of regulatory T cells in human autoimmune diseases
C Dejaco et al.
IMMUNOLOGY (2006)
Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
M. F. Roelofs et al.
ARTHRITIS RESEARCH & THERAPY (2005)
TLR2 modulates inflammation in zymosan-induced arthritis in mice
ME Frasnelli et al.
ARTHRITIS RESEARCH & THERAPY (2005)
TLR2 is expressed on activated T cells as a costimulatory receptor
M Komai-Koma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Leucine-rich repeats and pathogen recognition in Toll-like receptors
JK Bell et al.
TRENDS IN IMMUNOLOGY (2003)
Expression and regulation of toll-like receptor 2 in rheumatoid arthritis synovium
R Seibl et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Advances in immunology - Autoimmune diseases
A Davidson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide
TH Flo et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
